Our Company

Our story

Perspectum Diagnostics was founded in partnership with the University of Oxford in 2012 after a ground-breaking study demonstrated the potential of T1 mapping to predict liver fibrosis.

New ways of accurately diagnosing liver disease early are essential if health care systems are to tackle this growing issue, which is predicted to lead to many more cases of serious liver damage and people needing liver transplants.

Our work focuses on the detection and accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states.

More about us

Led by a dynamic and inspirational team, we are leading the way in delivering digital technologies that help clinicians to deliver better care for people with liver disorders.

Find out more about the people behind the technology.